semaglutide canada patent expiry Novo's Ozempic Expires Jan. 4 in Canada, But Generics Not Imminent As the patent for semaglutide,

Food and Drug Administration News Reports (NY Post / Verywell Health) contextualizes Retatrutide as the next-generation triple G therapy capable of greater weight loss, and notes timeline expectations for approval (~late 20252026) Wikipedia+15verywellhealth.com+15New York Post+15

Flippase is an enzyme active under basal conditions that shifts PS from the outer to the inner membrane leaflet, thereby preventing PS exposure

Ipamorelin Ipamorelin is a growth hormone-releasing peptide (GHRP) that complements CJC-1295

Treating both conditions is important, but are there effective treatment options that can simultaneously help treat ADHD and depression

Lipo B12+MIC FAQ What is Lipotropic (Lipo) B12+MIC